Maize-or potato-derived hydroxyethyl starches: Is there any thromboelastometric difference?

Acta Anaesthesiologica Scandinavica

Volumn 54, Issue 10, 2010, Pages 1241-1247

  Godier, A ^a,b   Durand, M ^c   Smadja, D ^a,d   Jeandel, T ^b   Emmerich, J ^a   Samama, C M ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔTEL DIEU   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHALASIN; FIBRINOGEN; HETASTARCH; RINGER LACTATE SOLUTION;

ARTICLE; BLOOD EXAMINATION; BLOOD SAMPLING; CRYSTALLOID; CYTOCHALASIN D MODIFIED THROMBOELASTOMETRY; EXTRINSIC THROMBOELASTOMETRY; HEMATOLOGICAL PROCEDURES; HEMODILUTION; HUMAN; HUMAN EXPERIMENT; INTRINSIC THROMBOELASTOMETRY; MAIZE; NONHUMAN; NORMAL HUMAN; POTATO; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOELASTOMETRY;

BLOOD COAGULATION; BLOOD PLATELETS; CYTOCHALASIN D; ELLAGIC ACID; FIBRINOGEN; HEMOSTASIS; HETASTARCH; HUMANS; ISOTONIC SOLUTIONS; NUCLEIC ACID SYNTHESIS INHIBITORS; PLASMA SUBSTITUTES; PLATELET COUNT; SALINE SOLUTION, HYPERTONIC; SOLANUM TUBEROSUM; THROMBELASTOGRAPHY; WHOLE BLOOD COAGULATION TIME; ZEA MAYS;

EID: 78650194254     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2010.02306.x     Document Type: Article

References (31)

1. FLUIDS Study Investigators for the Scandinavian Critical Care Trials Group. Preferences for colloid use in Scandinavian intensive care units. Acta Anaesthesiol Scand 2008;52:750-8.
2. Boldt J. Modern rapidly degradable hydroxyethyl starches: current concepts. Anesth Analg 2009;108:1574-82.
3. Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: differentproducts - different effects. Anesthesiology 2009;111:187-202.
4. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005;103:654-60.
5. Boldt J, Mengistu A. Balanced hydroxyethylstarch preparations: are they all the same? In-vitro thrombelastometry and whole blood aggregometry. Eur J Anaesthesiol 2009;26:1020-5.
6. Haynes GR, Havidich JE, Payne KJ. Why the food and drug administration changed the warning label for hetastarch. Anesthesiology 2004;101:560-1.
7. Treib J, Haass A, Pindur G, Miyachita C, Grauer MT, Jung F, Wenzel E, Schimrigk K. Highly substituted hydroxyethyl starch (HES200/0.62) leads to Type-I von Willebrand syndrome after repeated administration. Haemostasis 1996;26:210-3.
8. Stump DC, Strauss RG, Henriksen RA, Petersen RE, Saunders R. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion 1985;25:349-54.
9. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999;25:258-68.
10. Nielsen VG. Hydroxyethyl starch does not decrease prothrombin to thrombin conversion. Acta Anaesthesiol Scand 2008;52:163-4.
11. Franz A, Braunlich P, Gamsjager T, Felfernig M, Gustorff B, Kozek-Langenecker SA. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001;92:1402-7.
12. Thaler U, Deusch E, Kozek-Langenecker SA. In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions. Anaesthesia 2005;60:554-9.
13. Fenger-Eriksen C, Tønnesen E, Ingerslev J, Sørensen B. Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. J Thromb Haemost 2009;7:1099-105.
14. Boldt J. Seven misconceptions regarding volume therapy strategies-and their correction. Br J Anaesth 2009;103:147-51.
15. Boldt J, Suttner S, Brosch C, Lehmann A, Mengistu A. Influence on coagulation of a potato-derived hydroxethylstarch (HES 130/0.42) and a maize-derived hydroxethylstarch (HES 130/0.4) in patients undergoing cardiac surgery. Br J Anaesth 2009;102:191-7.
16. Lehmann G, Marx G, Förster H. Bioequivalence comparison between hydroxyethyl starch 130/0.42/6:1 and hydroxyethyl starch 130/0.4/9:1. Drugs RD 2007;8:229-40.
17. Hartert H. Blutgerinnungsstudien mit des Thrombleastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr 1948;26:577-83.
18. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005;27:81-90.
19. Lang T, Bauters A, Braun SL, Pötzsch B, von Pape KW, Kolde HJ, Lakner M. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005;16:301-10.
20. Lang T, Johanning K, Metzler H, Piepenbrock S, Solomon C, Rahe-Meyer N, Tanaka KA. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009;108:751-8.
21. Kettner SC, Panzer OP, Kozek SA, Seibt FA, Stoiser B, Kofler J, Locker GJ, Zimpfer M. Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anesth Analg 1999;89:580-4.
22. Boldt J, Wolf M, Mengistu A. A new plasma-adapted hydroxyethylstarch preparation: in vitro coagulation studies using thrombelastography and whole blood aggregometry. Anesth Analg 2007;104:425-30.
23. Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. The effect of potato starch derived and corn starch derived hydroxyethyl starch on in vitro blood coagulation. Anaesthesia 1998;53:638-44. (Pubitemid 28342395)
24. Lang T, Johanning K, Metzler H, Piepenbrock S, Solomon C, Rahe-Meyer N, Tanaka KA. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009;108:751-8.
25. Kheirabadi BS, Crissey JM, Deguzman R, Perez MR, Cox AB, Dubick MA, Holcomb JB. Effects of synthetic versus natural colloid resuscitation on inducing dilutional coagulopathy and increasing hemorrhage in rabbits. J Trauma 2008;64:1218-28.
26. Fries D, Haas T, Klingler A, Streif W, Klima G, Martini J, Wagner-Berger H, Innerhofer P. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy - a porcine model. Br J Anaesth 2006;97:460-7.
27. Fenger-Eriksen C, Anker-Møller E, Heslop J, Ingerslev J, Sørensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005;94:324-9.
28. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Oswald E, Bach C, Schnapka-Koepf M, Innerhofer P. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007;105:905-17.
29. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tønnesen E, Ingerslev J, Sørensen B. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009;7:795-802.
30. Scheingraber S, Rehm M, Sehmisch C, Finsterer U. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 1999;90:1265-70.
31. Handy JM, Soni N. Physiological effects of hyperchloraemia and acidosis. Br J Anaesth 2008;101:141-50.